A brief history of biopharmaceuticals - scientific drivers for adoption of large molecule therapeutics
Video, Sep 30 2020
Biochemistry Focus Webinar Series
60 minutes
During this webinar, Siân Estdale, Head of Scientific Affairs at Covance Laboratories Limited, presents a brief historical context for large molecules, the current market of approved large molecules, modalities and therapeutic targets.
At this event, she explores the mechanism of action of some blockbuster molecules and compare with small molecules. The major differences will be highlighted and finally the drug development pathway and probability of success will be discussed.
The webinar was chaired by Professor John Colyer, from the University of Leeds.
Share this page!
A brief history of biopharmaceuticals - scientific drivers for adoption of large molecule therapeutics
During this webinar, Siân Estdale, Head of Scientific Affairs at Covance Laboratories Limited, presents a brief historical context for large molecules, the current market of approved large molecules, modalities and therapeutic targets. At this event, she explores the mechanism of action of some blockbuster molecules and compare with small molecules. The major differences will be highlighted and finally the drug development pathway and probability of success will be discussed.
/media/edrjubuf/bcs20-1025_bio_focus_webinar_series_hero_1440x377_700.jpg